Ryan A. Altman earned his B.S. Chem. from Creighton University (2003) and a PhD in organic chemistry from the Massachusetts Institute of Technology (2008) working in the laboratory of Professor Stephen Buchwald, and completed postdoctoral fellowship with Professor Larry Overman at UC Irvine (2008-2011). He joined the Department of Medicinal Chemistry at The University of Kansas as an Assistant Professor, and after promotion to Associate Professor (2017), his group moved to Purdue University to join the Department of Medicinal Chemistry and Molecular Pharmacology and the Department of Chemistry (2020). The Altman group works at the interface of synthetic organic and medicinal chemistries, with synthetic emphases in the areas of organometallic and organofluorine transformations and unique chemical reactivities enabled by fluorinated substructures. The group's collaborative medicinal interests span a range of disease states, including pain, anxiety and mood disorders, and aging.